---
figid: PMC5471068__oncotarget-08-35445-g002
figlink: /pmc/articles/PMC5471068/figure/F2/
number: Figure 2
caption: 1) E/R regulates the phosphorylation of STAT3 via activation of RAC1, resulting
  in the transcriptional induction of MYC. 2) E/R can bind to a principal TGF-β signaling
  target, Smad3, which has an inhibitory impact on the response to TGF-β signaling.
  3) E/R can upregulate MDM2 promoter activity; MDM2 functions as a crucial negative
  regulator of p53, repressing its activity. 4) E/R activates PI3K/AKT/mTOR signaling
  and interferes with proliferation, cell adhesion and DNA damage response. Activation
  of PI3K/AKT/mTOR signaling also promotes the phosphorylation of MDM2 and its localization
  in the nucleus where it binds to p53. 5) E/R can directly bind the EPOR promoter
  and increase cell survival through activation of the JAK2-STAT5 pathway and upregulation
  of antiapoptotic BCL-XL. EPOR is also one of the upstream signaling components of
  the PI3K/AKT/mTOR signaling cascade. All these signal pathways facilitate the E/R
  pre-leukemic state.
pmcid: PMC5471068
papertitle: Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia
  and mechanisms underlying its relapse.
reftext: Congcong Sun, et al. Oncotarget. 2017 May 23;8(21):35445-35459.
pmc_ranked_result_index: '16861'
pathway_score: 0.9335283
filename: oncotarget-08-35445-g002.jpg
figtitle: Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia
  and mechanisms underlying its relapse
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5471068__oncotarget-08-35445-g002.html
  '@type': Dataset
  description: 1) E/R regulates the phosphorylation of STAT3 via activation of RAC1,
    resulting in the transcriptional induction of MYC. 2) E/R can bind to a principal
    TGF-β signaling target, Smad3, which has an inhibitory impact on the response
    to TGF-β signaling. 3) E/R can upregulate MDM2 promoter activity; MDM2 functions
    as a crucial negative regulator of p53, repressing its activity. 4) E/R activates
    PI3K/AKT/mTOR signaling and interferes with proliferation, cell adhesion and DNA
    damage response. Activation of PI3K/AKT/mTOR signaling also promotes the phosphorylation
    of MDM2 and its localization in the nucleus where it binds to p53. 5) E/R can
    directly bind the EPOR promoter and increase cell survival through activation
    of the JAK2-STAT5 pathway and upregulation of antiapoptotic BCL-XL. EPOR is also
    one of the upstream signaling components of the PI3K/AKT/mTOR signaling cascade.
    All these signal pathways facilitate the E/R pre-leukemic state.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MDM2
  - EPOR
  - JAK2
  - MYC
  - AKT2
  - PIK3R3
  - RAC1
  - SMAD3
  - AKT1
  - MTOR
  - PIK3R4
  - PIK3CA
  - TP53
  - AKT3
  - PIK3CG
  - PIK3R6
  - PIK3R5
  - SMAD7
  - STAT3
  - TGFB3
  - STAT5B
  - PIK3CB
  - PIK3CD
  - TGFB2
  - TGFB1
  - STAT5A
  - Cancer
genes:
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: EPOR
  symbol: EPOR
  source: hgnc_symbol
  hgnc_symbol: EPOR
  entrez: '2057'
- word: JAK2-
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: RAC1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: Smad3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: /MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: P53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: SMAD7
  symbol: SMAD7
  source: hgnc_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
